ABCLVSPRME• 28 Days (Normalized)
ABCL vs PRME (AbCellera Biologics Inc. vs Prime Medicine Inc.)
Showing Closing Date Range from Aug, 18 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ABCL Performance $11.41
+2.61%
AbCellera Biologics Inc.
Normalized Baseline0.00%
PRME Performance $3.14
+2.95%
Prime Medicine Inc.
Normalized Baseline0.00%
Alpha Spread Margin PRME LEADS
-0.34%
PRME outperforming by 0.34%
ABCLPRME
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ABCL PRME
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | ABCL Price | ABCL Gain (%) | PRME Price | PRME Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $11.41 | +2.61% | $3.14 | +2.95% | -0.34% |
| Sep 14, 2026 | $11.17 | +0.45% | $3.18 | +4.26% | -3.81% |
| Sep 11, 2026 | $10.89 | -2.07% | $3.13 | +2.62% | -4.69% |
| Sep 10, 2026 | $10.46 | -5.94% | $3.35 | +9.84% | -15.78% |
| Sep 09, 2026 | $11.05 | -0.63% | $3.47 | +13.77% | -14.40% |
| Sep 08, 2026 | $11.44 | +2.88% | $3.56 | +16.72% | -13.84% |
| Sep 04, 2026 | $11.43 | +2.79% | $3.70 | +21.31% | -18.52% |
| Sep 03, 2026 | $11.57 | +4.05% | $3.71 | +21.64% | -17.59% |
| Sep 02, 2026 | $11.36 | +2.16% | $3.67 | +20.33% | -18.17% |
| Sep 01, 2026 | $11.28 | +1.44% | $3.57 | +17.05% | -15.61% |
| Aug 31, 2026 | $11.48 | +3.24% | $3.59 | +17.70% | -14.46% |
| Aug 28, 2026 | $11.35 | +2.07% | $3.61 | +18.36% | -16.29% |
| Aug 27, 2026 | $12.40 | +11.51% | $3.64 | +19.34% | -7.83% |
| Aug 26, 2026 | $12.24 | +10.07% | $3.58 | +17.38% | -7.31% |
| Aug 25, 2026 | $12.50 | +12.41% | $3.71 | +21.64% | -9.23% |
Page 1 of 2